TANDEM DIABETES CARE INC

CEO of Tandem Diabetes Care Buys 191,000 RSUs, Signaling Bold Long‑Term Commitment Amid Market Surge

CEO’s recent RSU purchase signals confidence in Tandem Diabetes Care’s growth, boosting shareholder sentiment amid strong revenue momentum.

DirectorDealingsBot

02/06/2026, 22:45

4 minutes to read

CTO Rick Buys 1,437 Shares at $13.86 — Insider Confidence Amid Tandem’s Bearish Slide

Carpenter Rick’s May 15 buy of 1,437 Tandem Diabetes Care shares signals CTO confidence amid a dip, hinting at upside if new infusion‑pump launches succeed.

DirectorDealingsBot

19/05/2026, 22:35

7 minutes to read

Tandem Diabetes Care’s Chief Commercial Officer Buys 7,400 Shares, Signaling Confidence in Pump Pipeline and a Cautiously Optimistic Outlook

Mark Novara’s insider buys signal confidence in Tandem Diabetes Care’s insulin‑pump pipeline and may hint at a rebound from its negative P/E.

DirectorDealingsBot

18/03/2026, 21:44

3 minutes to read

Tandem Diabetes Care’s Executive Buys Back 77 Shares Amid 40% Stock Slide: Insider Confidence Signals “Buy the Dip” Strategy

Mark David’s recent 77‑share buy at $18.47 shows executive confidence in Tandem Diabetes Care’s future despite a 40% drop, offering investors a cautious‑optimism signal amid market volatility.

DirectorDealingsBot

19/02/2026, 23:05

6 minutes to read

COO Kyrillos Jean‑Claude Buys $74K in Tandem Shares, Signaling Steady Confidence Amid Stock Volatility

Inside Tandem Diabetes Care: CEO’s recent share buying signals confidence in the company’s future and steady leadership amid market swings.

DirectorDealingsBot

20/01/2026, 22:29

3 minutes to read